Search Results - "Rocío Aller de la Fuente"

Metabolomic‐based noninvasive serum test to diagnose nonalcoholic steatohepatitis: Results from discovery and validation cohorts by Mayo, Rebeca, Crespo, Javier, Martínez‐Arranz, Ibon, Banales, Jesus M, Arias, Mayte, Mincholé, Itziar, Aller de la Fuente, Rocío, Jimenez‐Agüero, Raúl, Alonso, Cristina, de Luis, Daniel A., Vitek, Libor, Stritesky, Jan, Caballería, Joan, Romero‐Gómez, Manuel, Martín‐Duce, Antonio, Mugüerza Huguet, Jose Maria, Busteros‐Moraza, José Ignacio, Idowu, Michael O., Castro, Azucena, Martínez‐Chantar, M. Luz, Ortiz, Pablo, Bruha, Radan, Lu, Shelly C., Bedossa, Pierre, Noureddin, Mazen, Sanyal, Arun J., Mato, José M.

“…Nonalcoholic fatty liver disease (NAFLD) is the most common type of chronic liver disease worldwide and includes a broad spectrum of histologic phenotypes,…”
Get full text

Nutrition and Chronic Liver Disease by Aller de la Fuente, Rocío

“…Malnutrition is common in chronic liver diseases and worsens the patient’s prognosis. Many liver disorders are associated with nutritional deficiencies. Some…”
Get full text

Metabolic subtypes of patients with NAFLD exhibit distinctive cardiovascular risk profiles by Martínez‐Arranz, Ibon, Bruzzone, Chiara, Noureddin, Mazen, Gil‐Redondo, Ruben, Mincholé, Itziar, Bizkarguenaga, Maider, Arretxe, Enara, Iruarrizaga‐Lejarreta, Marta, Fernández‐Ramos, David, Lopitz‐Otsoa, Fernando, Mayo, Rebeca, Embade, Nieves, Newberry, Elizabeth, Mittendorf, Bettina, Izquierdo‐Sánchez, Laura, Smid, Vaclav, Arnold, Jorge, Iruzubieta, Paula, Pérez Castaño, Ylenia, Krawczyk, Marcin, Marigorta, Urko M., Morrison, Martine C., Kleemann, Robert, Martín‐Duce, Antonio, Hayardeny, Liat, Vitek, Libor, Bruha, Radan, Aller de la Fuente, Rocío, Crespo, Javier, Romero‐Gomez, Manuel, Banales, Jesus M, Arrese, Marco, Cusi, Kenneth, Bugianesi, Elisabetta, Klein, Samuel, Lu, Shelly C., Anstee, Quentin M., Millet, Oscar, Davidson, Nicholas O., Alonso, Cristina, Mato, José M.

“…Background and Aims We previously identified subsets of patients with NAFLD with different metabolic phenotypes. Here we align metabolomic signatures with…”
Get full text

Acute calculous cholecystitis: a real-life management study in a tertiary teaching hospital by Busto Bea, Victoria, Caro Patón, Agustín, Aller Dela Fuente, Rocío, González Sagrado, Manuel, García-Alonso, Francisco Javier, Pérez-Miranda Castillo, Manuel

“…to describe the management of acute calculous cholecystitis in a tertiary teaching hospital and the outcomes obtained. a retrospective single tertiary center…”
Get full text

Analytical, anthropometric and dietary factors associated with the development of fibrosis in patients with nonalcoholic fatty liver disease by Gómez de la Cuesta, Sara, Aller de la Fuente, Rocío, Tafur Sánchez, Carla, Izaola, Olatz, García Sánchez, Concepción, Mora, Natalia, González Hernández, Jose Manuel, de Luis Román, Daniel

“…A prolonged non-alcoholic steatohepatitis (NASH) condition can lead to advanced stages of liver disease and the development of hepatocellular carcinoma. To…”
Get full text

Pathogenesis of occult chronic hepatitis B virus infection by de la Fuente, Rocio Aller, Gutiérrez, María L, Garcia-Samaniego, Javier, Fernández-Rodriguez, Conrado, Lledó, Jose Luis, Castellano, Gregorio

“…Occult hepatitis B infection（OBI） is characterized by hepatitis B virus（HBV） DNA in serum in the absence of hepatitis B surface antigen（HBsAg） presenting…”
Get full text

ABIDE: An Accurate Predictive Model of Liver Decompensation in Patients With Nonalcoholic Fatty Liver‐Related Cirrhosis by Calzadilla‐Bertot, Luis, Vilar‐Gomez, Eduardo, Wong, Vincent Wai‐Sun, Romero‐Gomez, Manuel, Aller‐de la Fuente, Rocio, Wong, Grace Lai‐Hung, Castellanos, Marlen, Eslam, Mohammed, Desai, Archita P., Jeffrey, Gary P., George, Jacob, Chalasani, Naga, Adams, Leon A.

“…Background and Aims Nonalcoholic fatty liver disease (NAFLD) is an increasingly important cause of liver cirrhosis and subsequent complications. We…”
Get full text

The practical utility of non-invasive indices in metabolic hepatic steatosis by Tafur Sánchez, Carla Noemi, Durá Gil, Miguel, Alemán Domínguez del Río, Andrea, Hernández Pérez, Celia María, Mora Cuadrado, Natalia, de la Cuesta, Sara Gómez, Primo Martín, David, de Luis Román, Daniel, de la Fuente, Rocío Aller

“…BACKGROUNDMetabolic hepatic steatosis (metHS) is the most frequent cause of chronic liver disease in our environment. The "gold standard" for its diagnosis…”
Get full text

Radiation enteritidis diagnosed by wireless capsule endoscopy by Ruiz-Rebollo, María Lourdes, de-la-Calle, Fernando, Velayos, Benito, Fernández-Salazar, Luis, Aller-de-la-Fuente, Rocío, González, José Manuel

Get full text

Factores analíticos, antropométricos y dietéticos asociados al desarrollo de fibrosis en pacientes con enfermedad por hígado graso no alcohólico by Gómez-de-la-Cuesta, Sara, Aller-de-la-Fuente, Rocío, Tafur-Sánchez, Carla, Izaola, Olatz, García-Sánchez, Concepción, Mora, Natalia, González-Hernández, José-Manuel, de-Luis-Román, Daniel

“…RESUMEN Antecedentes: la esteatohepatitis no alcohólica (EHNA) mantenida en el tiempo puede conducir a estadios avanzados de enfermedad hepática y al…”
Get full text

Histopathological differences in patients with biopsy-proven non-alcoholic fatty liver disease with and without type 2 diabetes by Aller de la Fuente, Rocío, Mora Cuadrado, Natalia, Tafur, Carla, López Gómez, Juan Jose, Gómez de la Cuesta, Sara, García Sánchez, María Concepción, Antolin Melero, Beatriz, de Luis Román, Daniel Antonio

“…Prevalence of non-alcoholic fatty liver disease (NAFLD) in developed countries is 30% in the general population and 50% in patients with type 2 diabetes…”
Get full text

Impact of the endoscopist's experience on the negative predictive value of capsule endoscopy by Velayos Jiménez, Benito, Alcaide Suárez, Noelia, González Redondo, Guillermo, Fernández Salazar, Luis, Aller de la Fuente, Rocío, Del Olmo Martínez, Lourdes, Ruiz Rebollo, Lourdes, González Hernández, José Manuel

“…The impact of the accumulated experience of the capsule endoscopy (CE) reader on the accuracy of this test is discussed. To determine whether the negative…”
Get more information

FIB-4 score as predictor of COVID-19-related severity in hospitalized patients by Lucena Valera, Ana, Aller Dela Fuente, Rocío, Sánchez Torrijos, Yolanda, Romero Gómez, Manuel, Ampuero Herrojo, Javier

“…To determine the impact of liver fibrosis on the prognosis of COVID and the liver injury associated with the infection. Retrospective multicenter study…”
Get full text

Leptin Receptor Lys656Asn Polymorphism Is Associated with Decreased Leptin Response and Weight Loss Secondary to a Lifestyle Modification in Obese Patients by de Luis Roman, Daniel, de la Fuente, Rocio Aller, Sagrado, Manuel Gonzalez, Izaola, Olatz, Vicente, Rosa Conde

“…Human obesity is characterized by high levels of leptin, and it has been suggested that obese patients may be leptin resistant. The aim of our study was to…”
Get full text

Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study by Vilar-Gomez, Eduardo, Calzadilla-Bertot, Luis, Wai-Sun Wong, Vincent, Castellanos, Marlen, Aller-de la Fuente, Rocio, Metwally, Mayada, Eslam, Mohammed, Gonzalez-Fabian, Licet, Alvarez-Quiñones Sanz, María, Conde-Martin, Antonio Felix, De Boer, Bastiaan, McLeod, Duncan, Hung Chan, Anthony Wing, Chalasani, Naga, George, Jacob, Adams, Leon A., Romero-Gomez, Manuel

“…Little is known about the natural course of nonalcoholic fatty liver disease (NAFLD) with advanced fibrosis. We describe long-term outcomes and evaluate the…”
Get full text

Histopathological differences in patients with biopsy-proven non-alcoholic fatty liver disease with and without type 2 diabetes by Aller de la Fuente, Rocío, Mora Cuadrado, Natalia, Tafur, Carla, López Gómez, Juan Jose, Gómez de la Cuesta, Sara, García Sánchez, María Concepción, Antolin Melero, Beatriz, de Luis Román, Daniel Antonio

“…Abstract Background and aims Prevalence of non-alcoholic fatty liver disease (NAFLD) in developed countries is 30% in the general population and 50% in…”
Get full text

Impact of the endoscopist's experience on the negative predictive value of capsule endoscopy by Velayos Jiménez, Benito, Alcaide Suárez, Noelia, González Redondo, Guillermo, Fernández Salazar, Luis, Aller de la Fuente, Rocío, del Olmo Martínez, Lourdes, Ruiz Rebollo, Lourdes, González Hernández, José Manuel

Get full text

Type 2 Diabetes and Metformin Use Associate With Outcomes of Patients With Nonalcoholic Steatohepatitis–Related, Child–Pugh A Cirrhosis by Vilar-Gomez, Eduardo, Calzadilla-Bertot, Luis, Wong, Vincent Wai-Sun, Castellanos, Marlen, Aller-de la Fuente, Rocio, Eslam, Mohammed, Wong, Grace Lai-Hung, George, Jacob, Romero-Gomez, Manuel, Adams, Leon A.

“…Factors that affect outcomes of patients with nonalcoholic steatohepatitis (NASH)-related cirrhosis are unclear. We studied associations of type 2 diabetes,…”
Get full text

Gastric metastasis from renal cell carcinoma by Gómez-de-la-Cuesta, Sara, Fernández-Salazar, Luis, Velayos-Jiménez, Benito, Macho-Conesa, Ana, Ruiz-Rebollo, Lourdes, Aller-de-la-Fuente, Rocío, González-Hernández, José Manuel

Get full text

Gastric metastasis from renal cell carcinoma Metástasis gástricas de carcinoma de células renales by Sara Gómez-de-la-Cuesta, Luis Fernández-Salazar, Benito Velayos-Jiménez, Ana Macho-Conesa, Lourdes Ruiz-Rebollo, Rocío Aller-de-la-Fuente, José Manuel González-Hernández

Get full text